$42.21
+0.86 (+2.08%)
At Close: Jul 31, 2026
Is AxoGen, Inc. (AXGN) Going to Burn These Hedge Funds?
10:41pm, Wednesday, 08'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Squarepoint Ops LLC Makes New $200,000 Investment in AxoGen, Inc (NASDAQ:AXGN)
06:40am, Wednesday, 08'th Jul 2020
Squarepoint Ops LLC bought a new position in shares of AxoGen, Inc (NASDAQ:AXGN) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 19,232 shar
AxoGen (NASDAQ:AXGN) Trading 26.9% Higher
06:32am, Friday, 03'rd Jul 2020
AxoGen, Inc (NASDAQ:AXGN)’s stock price traded up 26.9% on Wednesday . The company traded as high as $12.72 and last traded at $11.73, 4,252,326 shares traded hands during trading. An increase of 74
Canaccord Genuity Downgrades AxoGen (AXGN) to Hold - Markets
10:01am, Thursday, 02'nd Jul 2020
Canaccord Genuity analyst Kyle Rose downgraded AxoGen (AXGN – Research Report) to Hold yesterday and set a price target of
Analyst Explains Why They Downgraded Their Rating on AxoGen (AXGN) - Markets
02:25pm, Wednesday, 01'st Jul 2020
AxoGen (AXGN – Research Report) received a Hold rating from BTIG analyst Ryan Zimmerman today. The company’s shares closed last
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
11:00am, Wednesday, 01'st Jul 2020
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced a financing agreement with Oberland Capital and provided p
Head-To-Head Analysis: AxoGen (NASDAQ:AXGN) versus Natus Medical (NASDAQ:NTUS)
01:36am, Friday, 26'th Jun 2020
AxoGen (NASDAQ:AXGN) and Natus Medical (NASDAQ:NTUS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings,
AxoGen, Inc (NASDAQ:AXGN) Stock Holdings Increased by Rhumbline Advisers
04:21am, Wednesday, 10'th Jun 2020
Rhumbline Advisers raised its position in shares of AxoGen, Inc (NASDAQ:AXGN) by 2.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The ins
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced the appointment of Brad Ottinger as Gen
Edited Transcript of AXGN earnings conference call or presentation 6-May-20 8:30pm GMT
09:39am, Monday, 01'st Jun 2020
Q1 2020 AxoGen Inc Earnings Call
Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General ...
12:00am, Monday, 01'st Jun 2020Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference
11:00am, Wednesday, 20'th May 2020
ALACHUA, Fla., May 20, 2020 -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral.
Sign In
Buy AXGN